Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism

被引:48
作者
Kim, SJ [1 ]
Lee, HS [1 ]
Kim, CH [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Psychiat, Seoul 135720, South Korea
关键词
obsessive-compulsive disorder; serotonin transporter; polymorphism; component analysis;
D O I
10.1159/000088860
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recently, on the basis of the effects of serotonin (5-HT) reuptake inhibitors in obsessive-compulsive disorder (OCD) treatment, several candidate genes related to 5-HT regulation have been hypothesized to play an important role in the development of OCD. One of them is 5-HT transporter gene. Therefore, the aims of this study were to investigate the associations between 5-HT transporter polymorphism and OCD. One hundred and twenty-four OCD patients and 171 normal controls participated in this study. Genomic DNA was extracted from their blood. Comparison of the genotypes and allele frequencies of the SERTPR polymorphism between the OCD group and the control group was made. Using principal component analysis, we derived four factors from thirteen main contents of the Y-BOCS checklist and investigated the association between these four factors and the SERTPR polymorphism. In this case-control study, we could not find any associations between the SERTPR polymorphism and the development of OCD. In the OCD group, patients with the L genotype had higher scores for the religious/ somatic factor than with the S genotype. In conclusion, the SERTPR polymorphism does not affect the development of OCD. But SERTPR polymorphisms affect certain factors of OC symptoms. Moreover, the factor analytic approach used in the present study has identified meaningful symptom dimensions to help guide future research. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:176 / 182
页数:7
相关论文
共 31 条
  • [1] Altemus M, 1996, AM J MED GENET, V67, P409, DOI 10.1002/(SICI)1096-8628(19960726)67:4<409::AID-AJMG16>3.0.CO
  • [2] 2-N
  • [3] BAER L, 1994, J CLIN PSYCHIAT, V55, P18
  • [4] SEROTONIN UPTAKE AND IMIPRAMINE BINDING IN THE BLOOD-PLATELETS OF OBSESSIVE-COMPULSIVE DISORDER PATIENTS
    BASTANI, B
    ARORA, RC
    MELTZER, HY
    [J]. BIOLOGICAL PSYCHIATRY, 1991, 30 (02) : 131 - 139
  • [5] Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder
    Bengel, D
    Greenberg, BD
    Corá-Locatelli, G
    Altemus, M
    Heils, A
    Li, Q
    Murphy, DL
    [J]. MOLECULAR PSYCHIATRY, 1999, 4 (05) : 463 - 466
  • [6] Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene
    Billett, EA
    Richter, MA
    King, N
    Heils, A
    Lesch, KP
    Kennedy, JL
    [J]. MOLECULAR PSYCHIATRY, 1997, 2 (05) : 403 - 406
  • [7] The serotonin system and spiritual experiences
    Borg, J
    Andrée, B
    Soderstrom, H
    Farde, L
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (11) : 1965 - 1969
  • [8] Camarena B, 2001, INT J NEUROPSYCHOPH, V4, P269, DOI 10.1017/S1461145701002516
  • [9] Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism
    Cavallini, MC
    Di Bella, D
    Siliprandi, F
    Malchiodi, F
    Bellodi, L
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (03): : 347 - 353
  • [10] Obsessive-compulsive disorder, 5-HTTLPR polymorphism and treatment response
    Di Bella D.
    Erzegovesi S.
    Cavallini M.C.
    Bellodi L.
    [J]. The Pharmacogenomics Journal, 2002, 2 (3) : 176 - 181